Advanced search
Publication Cover
Postgraduate Medicine Volume 122, 2010 - Issue 4
Submit an article Journal homepage
31
Views
8
CrossRef citations to date
0
Altmetric
Clinical Features

Plasma Lp-PLA2 in Acute Coronary Syndrome: Association with Major Adverse Cardiac Events in a Community-Based Cohort

Ning Li Department of Cardiology, Shanghai Xuhui Central Hospital, Shanghai, PRC
, MD, MS,
Shuijun Li Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, PRC; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PRC
, PhD,
Chen Yu Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, PRC
, MB &
Shuiming Gu Department of Cardiology, Shanghai Xuhui Central Hospital, Shanghai, PRCCorrespondence[email protected]
, MD, PhD
Pages 200-205 | Published online: 13 Mar 2015

References

  • . Elinder LS, Dumitrescu A, Larsson P, Hedin U, Frostegard J, Claesson HE. Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall. Arterioscler Thromb Vasc Biol. 1997;17(10):2257–2263
  • . Leitinger N, Watson AD, Hama SY,. Role of group II secretory phospholipase: A2 in atherosclerosis. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol. 1999;19(5):1291–1298
  • . MacPhee CH, Moores KE, Boyd HF,. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J. 1999;338(pt 2):479–487
  • . Tjoelker LW, Wilder C, Eberhardt C,. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 1995;374(6522):549–553
  • . Grech ED, Ramsdale DR. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. BMJ. 326(7401):1259–1261
  • . Achar SA, Kundu S, Norcross WA. Diagnosis of acute coronary syndrome. Am Fam Physician. 2005;72(1):119–126
  • . Caslake MJ, Packard CJ, Suckling KE,. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis. 2000;150(2):413–419
  • . Packard CJ, O'Reilly DS, Caslake MJ,. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000;343(16):1148–1155
  • . Blake GJ, Dada N, Fox JC, Manson JE, Ridker PM. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women. J Am Coll Cardiol. 2001;38(5):1302–1306
  • . Ballantyne CM, Hoogeveen RC, Bang H,. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2004;109(7):837–842
  • . Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation. 2004;110(114):1903–1908
  • . Oei HH, van der Meer IM, Hofman A,. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation. 2005;111(5):570–575
  • . Kruse S, Mao XQ, Heinzmann A,. The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Am J Hum Genet. 2000;66(5):1522–1530
  • . Gerber Y. Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community. Atherosclerosis. 2009;203(2):593–598

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.